Skip to content
MedsAcross

Medicine

Detrol 2 mg tablet

Tolterodine · Oral · Viatris Specialty
Available on requestPrescription onlyUS FDA

Detrol 2 mg tablet is a prescription medicine containing Tolterodine for oral use, marketed by Viatris Specialty, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 25ºC (77ºF), excursions permitted to 15–30ºC (59–86ºF) (DTL).

Key facts

Active ingredient (INN)
Tolterodine
Brand
Detrol
Strength
2 mg
Dosage form
Tablet
Route
Oral
Packs
60 tablets
Marketing authorisation holder
Viatris Specialty
Manufacturer
Viatris Specialty
Origin register
US FDA, United States
Storage
Store at 25ºC (77ºF), excursions permitted to 15–30ºC (59–86ºF) (DTL).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
G04BD07 Tolterodine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 August 2024
Identifiers
RxCUI 855178, 855180, 855194 +1DailyMed set ID 41eb00d2-64e3-4ec9-8732-4bfc81b04180NDC 58151-099Application NDA020771

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
60 tablet, film coated in 1 bottle58151-099-91Viatris Specialty1 August 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 25 March 1998Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Tolterodine 2 mg tablet.

Compare 1

Other strengths and forms of Tolterodine

Clinical summary

Tolterodine is a cholinergic muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. It is available as extended-release capsules and tablets for oral use. MedsAcross supplies Tolterodine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Tolterodine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Detrol 2 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.